Ticker League

Bio-Techne (TECH) Free Cash Flow Bridge

Pinpoint what moved Bio-Techne's free cash flow from TTM through Q1 2025 to TTM through Q1 2026 — operating cash flow shifts and capex changes, each driver sized in dollars.

FCF YoY

+22.13%

OCF YoY

+11.33%

Capex YoY

-42.72%

FCF Conversion Δ

+8.1 pp

Free cash flow bridge for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025

Δ Free cash flow: $48.84M

FCF bridge breakdown for Bio-Techne (TECH) — TTM through Q1 2026 vs TTM through Q1 2025

  • Prior Free Cash Flow$220.75M
  • Operating Cash Flow$30.01M
  • Capital Expenditure$18.84M
  • Free Cash Flow$269.60M
Identity check: drivers reconcile to ΔNI within $0.00
Want to see how cash flow is built up?Cash Flow Waterfall

Frequently asked questions

Data & methodology